Immuneering IMRX
NASDAQ IMRX
$4.09 -0.04 (-0.97%)
At close: Sep 30, 2026 · 4:00 PM EDT

Immuneering (IMRX) Change in Receivables (2020 - 2023)

Updated

Immuneering (IMRX) reported Change in Receivables of -$12,417 for FY2023, compared with -$233,623 in FY2022.

Analysis

Immuneering (IMRX) Change in Receivables (2020 - 2023) Analysis & Trends

Dating back to FY2020, Immuneering's Change in Receivables record includes 4 years.

  • The FY2023 figure ranks as the highest annual Change in Receivables since FY2020.
  • According to Business Quant data, Change in Receivables came in at -$233,623 in FY2022, -$279,713 in FY2021 and $290,170 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.35 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.37 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.09 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 333.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 140.20 Mn
10 Immuneering 264.61 Mn 264.61 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 -1,046.00
Mar 31, 2023 -11,371.00
Dec 31, 2022 -57,763.00
Sep 30, 2022 -108,245.00
Jun 30, 2022 -101,188.00
Mar 31, 2022 33,573.00
Dec 31, 2021 -250,978.00
Sep 30, 2021 -23,730.00
Jun 30, 2021 2,700.00
Mar 31, 2021 -7,705.00
Dec 31, 2020 -78,035.00
Sep 30, 2020 278,185.00
API Access

Immuneering Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=IMRX&period=max&api_key=YOUR_API_KEY